Advanced search
Publication Cover
Molecular and Cellular Biology Volume 35, 2015 - Issue 2
Submit an article Journal homepage
61
Views
44
CrossRef citations to date
0
Altmetric
Article

Cyclin-Dependent Kinase 12 Increases 3′ End Processing of Growth Factor-Induced c-FOS Transcripts

Tristan T. Eiflera Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USACorrespondence[email protected] [email protected]
,
Wei Shaoa Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA
,
Koen Bartholomeeusena Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA
,
Koh Fujinagaa Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA
,
Stefanie Jägerb Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California, USA;c California Institute for Quantitative Biosciences, QB3, San Francisco, California, USA
,
Jeff R. Johnsonb Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California, USA;c California Institute for Quantitative Biosciences, QB3, San Francisco, California, USA
,
Zeping Luoa Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA
,
Nevan J. Kroganb Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California, USA;c California Institute for Quantitative Biosciences, QB3, San Francisco, California, USA
&
B. Matija Peterlina Department of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USACorrespondence[email protected] [email protected]
 show all
Pages 468-478 | Received 14 Sep 2014, Accepted 01 Nov 2014, Published online: 20 Mar 2023

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Danielle E Lyons, Sarah McMahon & Melanie Ott. (2020) A combinatorial view of old and new RNA polymerase II modifications. Transcription 11:2, pages 66-82.
Read now
Arno L. Greenleaf. (2019) Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium. Transcription 10:2, pages 91-110.
Read now
Michael Tellier, Ivan Ferrer-Vicens & Shona Murphy. (2016) The point of no return: The poly(A)-associated elongation checkpoint. RNA Biology 13:3, pages 265-271.
Read now

Articles from other publishers (41)

Min Qiu, Zhinang Yin, Honghong Wang, Lingyu Lei, Conghui Li, Yali Cui, Rong Dai, Peiyuan Yang, Ying Xiang, Qiuzi Li, Junhui LvZhuang Hu, Min ChenHai-Bing Zhou, Pingping Fang, Ruijing Xiao & Kaiwei Liang. (2023) CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. Science Advances 9:20.
Crossref
Tapan K. Maity, Eun Young Kim, Constance M. Cultraro, Abhilash Venugopalan, Leena Khare, Ramulu Poddutoori, Sivapriya Marappan, Samiulla D. Syed, William G. Telford, Susanta Samajdar, Murali Ramachandra & Udayan Guha. (2023) Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. Cancers 15:8, pages 2263.
Crossref
Koh Fujinaga, Fang Huang & B. Matija Peterlin. (2023) P-TEFb: The master regulator of transcription elongation. Molecular Cell 83:3, pages 393-403.
Crossref
Wence Wu, Shengji Yu & Xiying Yu. (2023) Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:1, pages 188842.
Crossref
Michael Tellier, Justyna Zaborowska, Jonathan Neve, Takayuki Nojima, Svenja Hester, Marjorie Fournier, Andre Furger & Shona Murphy. (2022) CDK9 and PP2A regulate RNA polymerase II transcription termination and coupled RNA maturation . EMBO reports 23:10.
Crossref
Brian Magnuson, Karan Bedi, Ishwarya Venkata Narayanan, Bartlomiej Bartkowiak, Hailey Blinkiewicz, Michelle T. Paulsen, Arno Greenleaf & Mats Ljungman. (2022) CDK12 regulates co-transcriptional splicing and RNA turnover in human cells. iScience 25:9, pages 105030.
Crossref
Jianzhang Yang, Yu Chang, Jean Ching-Yi Tien, Zhen Wang, Yang Zhou, Pujuan Zhang, Weixue Huang, Josh Vo, Ingrid J. Apel, Cynthia Wang, Victoria Zhixuan Zeng, Yunhui Cheng, Shuqin Li, George Xiaoju Wang, Arul M. Chinnaiyan & Ke Ding. (2022) Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13. Journal of Medicinal Chemistry 65:16, pages 11066-11083.
Crossref
Alex M. Francette, Sarah A. Tripplehorn & Karen M. Arndt. (2021) The Paf1 Complex: A Keystone of Nuclear Regulation Operating at the Interface of Transcription and Chromatin. Journal of Molecular Biology 433:14, pages 166979.
Crossref
Sylvain Egloff. (2021) CDK9 keeps RNA polymerase II on track. Cellular and Molecular Life Sciences 78:14, pages 5543-5567.
Crossref
Solomon Tadesse, Derek R Duckett & Andrii Monastyrskyi. (2021) The promise and current status of CDK12/13 inhibition for the treatment of cancer. Future Medicinal Chemistry 13:2, pages 117-141.
Crossref
Fatemeh Emadi, Theodosia Teo, Muhammed H. Rahaman & Shudong Wang. (2020) CDK12: a potential therapeutic target in cancer. Drug Discovery Today 25:12, pages 2257-2267.
Crossref
Michael Tellier, Justyna Zaborowska, Livia Caizzi, Eusra Mohammad, Taras Velychko, Björn Schwalb, Ivan Ferrer-Vicens, Daniel Blears, Takayuki Nojima, Patrick Cramer & Shona Murphy. (2020) CDK12 globally stimulates RNA polymerase II transcription elongation and carboxyl-terminal domain phosphorylation. Nucleic Acids Research 48:14, pages 7712-7727.
Crossref
Pabitra K. Parua & Robert P. Fisher. (2020) Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors. Nature Chemical Biology 16:7, pages 716-724.
Crossref
Shujing Liang, Lifang Hu, Zixiang Wu, Zhihao Chen, Shuyu Liu, Xia Xu & Airong Qian. (2020) CDK12: A Potent Target and Biomarker for Human Cancer Therapy. Cells 9:6, pages 1483.
Crossref
Zheng Fan, Jennifer R. Devlin, Simon J. Hogg, Maria A. DoylePaul F. Harrison, Izabela TodorovskiLeonie A. Cluse, Deborah A. Knight, Jarrod J. SandowGareth Gregory, Andrew Fox, Traude H. BeilharzNicholas Kwiatkowski, Nichollas E. Scott, Ana Tufegdzic VidakovicGavin P. Kelly, Jesper Q. Svejstrup, Matthias Geyer, Nathanael S. Gray, Stephin J. Vervoort & Ricky W. Johnstone. (2020) CDK13 cooperates with CDK12 to control global RNA polymerase II processivity. Science Advances 6:18.
Crossref
Seung Hyuk Choi, Seongjae Kim & Katherine A. Jones. (2020) Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation. Experimental & Molecular Medicine 52:5, pages 762-771.
Crossref
Jonathan Chou, David A. Quigley, Troy M. Robinson, Felix Y. Feng & Alan Ashworth. (2020) Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Cancer Discovery 10:3, pages 351-370.
Crossref
Kveta Pilarova, Jan Herudek & Dalibor Blazek. (2020) CDK12: cellular functions and therapeutic potential of versatile player in cancer. NAR Cancer 2:1.
Crossref
Michael Robert Murphy & Frida Esther Kleiman. (2019) Connections between 3′ end processing and DNA damage response: Ten years later. WIREs RNA 11:2.
Crossref
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie & Peng Liu. (2020) CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling. Current Cancer Drug Targets 20:2, pages 156-165.
Crossref
Bartlomiej Bartkowiak, Christopher M. Yan, Erik J. Soderblom & Arno L. Greenleaf. (2019) CDK12 Activity-Dependent Phosphorylation Events in Human Cells. Biomolecules 9:10, pages 634.
Crossref
Anil Paul Chirackal Manavalan, Kveta Pilarova, Michael Kluge, Koen Bartholomeeusen, Michal Rajecky, Jan Oppelt, Prashant Khirsariya, Kamil Paruch, Lumir Krejci, Caroline C Friedel & Dalibor Blazek. (2019) CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes. EMBO reports 20:9.
Crossref
Malgorzata Krajewska, Ruben Dries, Andrew V. Grassetti, Sofia Dust, Yang Gao, Hao Huang, Bandana Sharma, Daniel S. Day, Nicholas Kwiatkowski, Monica Pomaville, Oliver Dodd, Edmond Chipumuro, Tinghu Zhang, Arno L. Greenleaf, Guo-Cheng Yuan, Nathanael S. Gray, Richard A. Young, Matthias Geyer, Scott A. Gerber & Rani E. George. (2019) CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation. Nature Communications 10:1.
Crossref
Seung H. Choi, Thomas F. Martinez, Seongjae Kim, Cynthia Donaldson, Maxim N. Shokhirev, Alan Saghatelian & Katherine A. Jones. (2019) CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability. Genes & Development 33:7-8, pages 418-435.
Crossref
Masahiro Ito, Toshio Tanaka, Akinori Toita, Noriko Uchiyama, Hironori Kokubo, Nao Morishita, Michael G. Klein, Hua Zou, Morio Murakami, Mitsuyo Kondo, Tomoya Sameshima, Shinsuke Araki, Satoshi Endo, Tomohiro Kawamoto, Gregg B. Morin, Samuel A. Aparicio, Atsushi Nakanishi, Hironobu Maezaki & Yasuhiro Imaeda. (2018) Discovery of 3-Benzyl-1-( trans -4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors . Journal of Medicinal Chemistry 61:17, pages 7710-7728.
Crossref
Myth T. Mok, Jingying Zhou, Wenshu Tang, Xuezhen Zeng, Antony W. Oliver, Simon E. Ward & Alfred S. Cheng. (2018) CCRK is a novel signalling hub exploitable in cancer immunotherapy. Pharmacology & Therapeutics 186, pages 138-151.
Crossref
Hana Paculová & Jiří Kohoutek. (2017) The emerging roles of CDK12 in tumorigenesis. Cell Division 12:1.
Crossref
Jerry F. Tien, Alborz Mazloomian, S.-W. Grace Cheng, Christopher S. Hughes, Christalle C.T. Chow, Leanna T. Canapi, Arusha Oloumi, Genny Trigo-Gonzalez, Ali Bashashati, James Xu, Vicky C.-D. Chang, Sohrab P. Shah, Samuel Aparicio & Gregg B. Morin. (2017) CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion. Nucleic Acids Research 45:11, pages 6698-6716.
Crossref
Steven R. Whittaker, Aurélie Mallinger, Paul Workman & Paul A. Clarke. (2017) Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacology & Therapeutics 173, pages 83-105.
Crossref
Rosaria Chilà, Federica Guffanti & Giovanna Damia. (2016) Role and therapeutic potential of CDK12 in human cancers. Cancer Treatment Reviews 50, pages 83-88.
Crossref
Tinghu Zhang, Nicholas Kwiatkowski, Calla M Olson, Sarah E Dixon-Clarke, Brian J Abraham, Ann K Greifenberg, Scott B Ficarro, Jonathan M Elkins, Yanke Liang, Nancy M Hannett, Theresa Manz, Mingfeng Hao, Bartlomiej Bartkowiak, Arno L Greenleaf, Jarrod A Marto, Matthias Geyer, Alex N Bullock, Richard A Young & Nathanael S Gray. (2016) Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. Nature Chemical Biology 12:10, pages 876-884.
Crossref
Justyna Zaborowska, Sylvain Egloff & Shona Murphy. (2016) The pol II CTD: new twists in the tail. Nature Structural & Molecular Biology 23:9, pages 771-777.
Crossref
Wei Shao, Kristina Zumer, Koh Fujinaga & B. Matija Peterlin. (2016) FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator). Journal of Biological Chemistry 291:34, pages 17953-17963.
Crossref
Célia Jeronimo, Pierre Collin & François Robert. (2016) The RNA Polymerase II CTD: The Increasing Complexity of a Low-Complexity Protein Domain. Journal of Molecular Biology 428:12, pages 2607-2622.
Crossref
Xuan Li, Nirmalya Chatterjee, Kerstin Spirohn, Michael Boutros & Dirk Bohmann. (2016) Cdk12 Is A Gene-Selective RNA Polymerase II Kinase That Regulates a Subset of the Transcriptome, Including Nrf2 Target Genes. Scientific Reports 6:1.
Crossref
Ann Katrin Greifenberg, Dana Hönig, Kveta Pilarova, Robert Düster, Koen Bartholomeeusen, Christian A. Bösken, Kanchan Anand, Dalibor Blazek & Matthias Geyer. (2016) Structural and Functional Analysis of the Cdk13/Cyclin K Complex. Cell Reports 14:2, pages 320-331.
Crossref
Sarah E. Dixon-Clarke, Jonathan M. Elkins, S.-W. Grace Cheng, Gregg B. Morin & Alex N. Bullock. (2015) Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding. Scientific Reports 5:1.
Crossref
Lixia PanWenbing XieKai-Le LiZhihao YangJiang Xu, Wenhao Zhang, Lu-Ping LiuXingjie RenZhimin HeJunyu WuJin SunHui-Min WeiDaliang WangWei Xie, Wei LiJian-Quan NiFang-Lin Sun. (2015) Heterochromatin remodeling by CDK12 contributes to learning in Drosophila . Proceedings of the National Academy of Sciences 112:45, pages 13988-13993.
Crossref
Vladimir Pak, Tristan T. Eifler, Stefanie Jäger, Nevan J. Krogan, Koh Fujinaga & B. Matija Peterlin. (2015) CDK11 in TREX/THOC Regulates HIV mRNA 3′ End Processing. Cell Host & Microbe 18:5, pages 560-570.
Crossref
Bartlomiej Bartkowiak, Christopher Yan & Arno L. Greenleaf. (2015) Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:9, pages 1179-1187.
Crossref
Kingsley M. Ekumi, Hana Paculova, Tina Lenasi, Vendula Pospichalova, Christian A. Bösken, Jana Rybarikova, Vitezslav Bryja, Matthias Geyer, Dalibor Blazek & Matjaz Barboric. (2015) Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex. Nucleic Acids Research 43:5, pages 2575-2589.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.